View in EDS HTML Full Text PDF Full Text

Momelotinib Is Effective in Treatment for VEXAS Syndrome: Two Cases Within the AGMT Austrian Myeloid Registry.

Saved in:
Bibliographic Details
Title: Momelotinib Is Effective in Treatment for VEXAS Syndrome: Two Cases Within the AGMT Austrian Myeloid Registry.
Authors: Kiem, Dominik1,2 (AUTHOR), Leisch, Michael1,2,3 (AUTHOR), Toth, Ildiko1,2 (AUTHOR), Mayer, Marie‐Christina1,2 (AUTHOR), Pleyer, Lisa1,2,3 (AUTHOR), Greil, Richard1,2,3 (AUTHOR), Egle, Alexander1,2,3 (AUTHOR), Melchardt, Thomas1,2 (AUTHOR) t.melchardt@salk.at
Source: European Journal of Haematology. Sep2025, Vol. 115 Issue 3, p299-302. 4p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09024441
DOI:10.1111/ejh.14445